15-12B 1 a19-16604_21512b.htm 15-12B

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

Commission File Number  

001-31441

 

Select Medical Corporation

(Exact name of registrant as specified in its charter)

 

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(717) 972-1100

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

6.375% Senior Notes due 2021

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

o

 

 

 

 

 

Rule 12g-4(a)(2)

o

 

 

 

 

 

Rule 12h-3(b)(1)(i)

x

 

 

 

 

 

Rule 12h-3(b)(1)(ii)

o

 

 

 

 

 

Rule 15d-6

o

 

 

 

 

 

Rule 15d-22(b)

o

 

 

 

 

 

Approximate number of holders of record as of the certification or notice date: 0

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Select Medical Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:

August 5, 2019

 

By:

/s/ Michael E. Tarvin

 

 

 

 

Name:

Michael E. Tarvin

 

 

 

 

Title:

Executive Vice President, General Counsel and Secretary